288 related articles for article (PubMed ID: 28841151)
1. CCR7 Sulfotyrosine Enhances CCL21 Binding.
Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.
Jørgensen AS; Brandum EP; Mikkelsen JM; Orfin KA; Boilesen DR; Egerod KL; Moussouras NA; Vilhardt F; Kalinski P; Basse P; Chen YH; Yang Z; Dwinell MB; Volkman BF; Veldkamp CT; Holst PJ; Lahl K; Goth CK; Rosenkilde MM; Hjortø GM
Cell Mol Life Sci; 2021 Nov; 78(21-22):6963-6978. PubMed ID: 34586443
[TBL] [Abstract][Full Text] [Related]
3. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
Front Immunol; 2019; 10():2156. PubMed ID: 31572374
[TBL] [Abstract][Full Text] [Related]
4. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of CCL21 and identification of a putative CCR7 binding site.
Love M; Sandberg JL; Ziarek JJ; Gerarden KP; Rode RR; Jensen DR; McCaslin DR; Peterson FC; Veldkamp CT
Biochemistry; 2012 Jan; 51(3):733-5. PubMed ID: 22221265
[TBL] [Abstract][Full Text] [Related]
6. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
Hauser MA; Legler DF
J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
[TBL] [Abstract][Full Text] [Related]
7. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
[TBL] [Abstract][Full Text] [Related]
8. Crystallographic Structure of Truncated CCL21 and the Putative Sulfotyrosine-Binding Site.
Smith EW; Lewandowski EM; Moussouras NA; Kroeck KG; Volkman BF; Veldkamp CT; Chen Y
Biochemistry; 2016 Oct; 55(40):5746-5753. PubMed ID: 27617343
[TBL] [Abstract][Full Text] [Related]
9. Structural Insights into Molecular Recognition by Human Chemokine CCL19.
Lewandowski EM; Kroeck KG; Jacobs LMC; Fenske TG; Witt RN; Hintz AM; Ramsden ER; Zhang X; Peterson F; Volkman BF; Veldkamp CT; Chen Y
Biochemistry; 2022 Mar; 61(5):311-318. PubMed ID: 35156805
[TBL] [Abstract][Full Text] [Related]
10. Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.
Moussouras NA; Getschman AE; Lackner ER; Veldkamp CT; Dwinell MB; Volkman BF
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869519
[TBL] [Abstract][Full Text] [Related]
11. Structural Features of an Extended C-Terminal Tail Modulate the Function of the Chemokine CCL21.
Moussouras NA; Hjortø GM; Peterson FC; Szpakowska M; Chevigné A; Rosenkilde MM; Volkman BF; Dwinell MB
Biochemistry; 2020 Apr; 59(13):1338-1350. PubMed ID: 32182428
[TBL] [Abstract][Full Text] [Related]
12. Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.
Barmore AJ; Castex SM; Gouletas BA; Griffith AJ; Metz SW; Muelder NG; Populin MJ; Sackett DM; Schuster AM; Veldkamp CT
Biochem Biophys Res Commun; 2016 Sep; 477(4):602-606. PubMed ID: 27338641
[TBL] [Abstract][Full Text] [Related]
13. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.
Jørgensen AS; Adogamhe PE; Laufer JM; Legler DF; Veldkamp CT; Rosenkilde MM; Hjortø GM
J Leukoc Biol; 2018 Aug; 104(2):401-411. PubMed ID: 29768676
[TBL] [Abstract][Full Text] [Related]
14. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
[TBL] [Abstract][Full Text] [Related]
15. Differential ligand-signaling network of CCL19/CCL21-CCR7 system.
Raju R; Gadakh S; Gopal P; George B; Advani J; Soman S; Prasad TS; Girijadevi R
Database (Oxford); 2015; 2015():. PubMed ID: 26504105
[TBL] [Abstract][Full Text] [Related]
16. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
[TBL] [Abstract][Full Text] [Related]
17. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.
Artinger M; Gerken OJ; Legler DF
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182
[TBL] [Abstract][Full Text] [Related]
18. Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.
Jørgensen AS; Rosenkilde MM; Hjortø GM
Gen Comp Endocrinol; 2018 Mar; 258():4-14. PubMed ID: 28694053
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
Haessler U; Pisano M; Wu M; Swartz MA
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
[TBL] [Abstract][Full Text] [Related]
20. CCL21/CCR7 axis as a therapeutic target for autoimmune diseases.
Han L; Zhang L
Int Immunopharmacol; 2023 Aug; 121():110431. PubMed ID: 37331295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
